DP VII Associates L.P., 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 6,708 shares at $6.93 ($46K) on 2009-11-20, disclosed to the SEC on 2009-11-24.
Open-market purchase of $46k OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.93 | 4,192 | $29K | 62.5% |
| 2 | $6.93 | 2,516 | $17K | 37.5% |
| Total | $6.93 avg | 6,708 | $46K | 100% |
| Filing → |
| EVOK | SELL | 2016-04-21 | $4K | — | Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |
| ESPR | BUY | 2013-07-02 | $67K | — | Filing → |